APO Research
Talk to an analyst

APO RESEARCH · REPORT

Guided Tissue Regeneration (GTR) Membrane

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Guided Tissue Regeneration (GTR) Membrane Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchGuided Tissue Regeneration (GTR) Membrane Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Guided Tissue Regeneration (GTR) Membrane Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Guided Tissue Regeneration (GTR) Membrane Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Guided Tissue Regeneration (GTR) Membrane Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Guided Tissue Regeneration (GTR) Membrane Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Guided Tissue Regeneration (GTR) Membrane market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Guided Tissue Regeneration (GTR) Membrane is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Guided Tissue Regeneration (GTR) Membrane market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Guided Tissue Regeneration (GTR) Membrane market include Geistlich, Zimmer Biomet, Yantai Zhenghai Bio-tech, Botiss Biomaterials, Danaher Corporation, Sunstar, Dentsply Sirona, ACE Surgical and OraPharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Guided Tissue Regeneration (GTR) Membrane market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Guided Tissue Regeneration (GTR) Membrane and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Guided Tissue Regeneration (GTR) Membrane sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Guided Tissue Regeneration (GTR) Membrane market size, projected growth trends, production technologies, key applications, and end-use industries.

Guided Tissue Regeneration (GTR) Membrane Segment by Company

Geistlich

Zimmer Biomet

Yantai Zhenghai Bio-tech

Botiss Biomaterials

Danaher Corporation

Sunstar

Dentsply Sirona

ACE Surgical

OraPharma

Neoss Limited

Keystone Dental

BEGO

Bioteck

Dentegris

Genoss

Guided Tissue Regeneration (GTR) Membrane Segment by Type

Absorbable Membrane

Non-absorbable Membrane

Guided Tissue Regeneration (GTR) Membrane Segment by Application

Hospital

Dental Clinic

Guided Tissue Regeneration (GTR) Membrane Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Guided Tissue Regeneration (GTR) Membrane status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Guided Tissue Regeneration (GTR) Membrane market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Guided Tissue Regeneration (GTR) Membrane significant trends, drivers, influence factors in global and regions.

6. To analyze Guided Tissue Regeneration (GTR) Membrane competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guided Tissue Regeneration (GTR) Membrane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Guided Tissue Regeneration (GTR) Membrane and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guided Tissue Regeneration (GTR) Membrane.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Guided Tissue Regeneration (GTR) Membrane market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Guided Tissue Regeneration (GTR) Membrane industry.

Chapter 3: Detailed analysis of Guided Tissue Regeneration (GTR) Membrane manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Guided Tissue Regeneration (GTR) Membrane in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Guided Tissue Regeneration (GTR) Membrane in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Guided Tissue Regeneration (GTR) Membrane Industry Trends Table 2. Guided Tissue Regeneration (GTR) Membrane Industry Drivers Table 3. Guided Tissue Regeneration (GTR) Membrane Industry Opportunities and Challenges Table 4. Guided Tissue Regeneration (GTR) Membrane Industry Restraints Table 5. Global Guided Tissue Regeneration (GTR) Membrane Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Guided Tissue Regeneration (GTR) Membrane Revenue Share by Company (2021-2026) Table 7. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Company (2021-2026) Table 9. Global Guided Tissue Regeneration (GTR) Membrane Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Guided Tissue Regeneration (GTR) Membrane Company Ranking, (2024-2026) & (USD Million) Table 11. Global Guided Tissue Regeneration (GTR) Membrane Key Company Manufacturing Base & Headquarters Table 12. Global Guided Tissue Regeneration (GTR) Membrane Company, Product Type & Application Table 13. Global Guided Tissue Regeneration (GTR) Membrane Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Guided Tissue Regeneration (GTR) Membrane by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Absorbable Membrane Table 18. Significant Companies of Non-absorbable Membrane Table 19. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2026) Table 23. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2027-2032) Table 24. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2026) Table 28. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Dental Clinic Table 31. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2026) Table 35. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2027-2032) Table 36. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2026) Table 40. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2027-2032) Table 41. Global Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2026) & (K Units) Table 43. Global Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2021-2026) Table 44. Global Guided Tissue Regeneration (GTR) Membrane Sales by Region (2027-2032) & (K Units) Table 45. Global Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region (2027-2032) Table 46. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region (2021-2026) Table 49. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region (2027-2032) Table 51. Global Guided Tissue Regeneration (GTR) Membrane Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Guided Tissue Regeneration (GTR) Membrane Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Guided Tissue Regeneration (GTR) Membrane Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2026) & (K Units) Table 56. Global Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Country (2021-2026) Table 57. Global Guided Tissue Regeneration (GTR) Membrane Sales by Country (2027-2032) & (K Units) Table 58. Global Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Country (2027-2032) Table 59. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Market Share by Country (2021-2026) Table 61. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Market Share by Country (2027-2032) Table 63. Geistlich Company Information Table 64. Geistlich Business Overview Table 65. Geistlich Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Geistlich Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 67. Geistlich Recent Development Table 68. Zimmer Biomet Company Information Table 69. Zimmer Biomet Business Overview Table 70. Zimmer Biomet Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zimmer Biomet Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 72. Zimmer Biomet Recent Development Table 73. Yantai Zhenghai Bio-tech Company Information Table 74. Yantai Zhenghai Bio-tech Business Overview Table 75. Yantai Zhenghai Bio-tech Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Yantai Zhenghai Bio-tech Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 77. Yantai Zhenghai Bio-tech Recent Development Table 78. Botiss Biomaterials Company Information Table 79. Botiss Biomaterials Business Overview Table 80. Botiss Biomaterials Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Botiss Biomaterials Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 82. Botiss Biomaterials Recent Development Table 83. Danaher Corporation Company Information Table 84. Danaher Corporation Business Overview Table 85. Danaher Corporation Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Danaher Corporation Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 87. Danaher Corporation Recent Development Table 88. Sunstar Company Information Table 89. Sunstar Business Overview Table 90. Sunstar Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sunstar Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 92. Sunstar Recent Development Table 93. Dentsply Sirona Company Information Table 94. Dentsply Sirona Business Overview Table 95. Dentsply Sirona Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dentsply Sirona Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 97. Dentsply Sirona Recent Development Table 98. ACE Surgical Company Information Table 99. ACE Surgical Business Overview Table 100. ACE Surgical Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. ACE Surgical Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 102. ACE Surgical Recent Development Table 103. OraPharma Company Information Table 104. OraPharma Business Overview Table 105. OraPharma Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. OraPharma Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 107. OraPharma Recent Development Table 108. Neoss Limited Company Information Table 109. Neoss Limited Business Overview Table 110. Neoss Limited Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Neoss Limited Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 112. Neoss Limited Recent Development Table 113. Keystone Dental Company Information Table 114. Keystone Dental Business Overview Table 115. Keystone Dental Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Keystone Dental Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 117. Keystone Dental Recent Development Table 118. BEGO Company Information Table 119. BEGO Business Overview Table 120. BEGO Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. BEGO Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 122. BEGO Recent Development Table 123. Bioteck Company Information Table 124. Bioteck Business Overview Table 125. Bioteck Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bioteck Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 127. Bioteck Recent Development Table 128. Dentegris Company Information Table 129. Dentegris Business Overview Table 130. Dentegris Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Dentegris Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 132. Dentegris Recent Development Table 133. Genoss Company Information Table 134. Genoss Business Overview Table 135. Genoss Guided Tissue Regeneration (GTR) Membrane Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Genoss Guided Tissue Regeneration (GTR) Membrane Product Portfolio Table 137. Genoss Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Guided Tissue Regeneration (GTR) Membrane Distributors List Table 141. Guided Tissue Regeneration (GTR) Membrane Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Guided Tissue Regeneration (GTR) Membrane Product Image Figure 2. Global Guided Tissue Regeneration (GTR) Membrane Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 4. Global Guided Tissue Regeneration (GTR) Membrane Sales (2021-2032) & (K Units) Figure 5. Global Guided Tissue Regeneration (GTR) Membrane Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Guided Tissue Regeneration (GTR) Membrane Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Absorbable Membrane Image Figure 10. Non-absorbable Membrane Image Figure 11. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2032) Figure 14. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Dental Clinic Image Figure 19. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2032) Figure 22. Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2032) Figure 25. Global Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Guided Tissue Regeneration (GTR) Membrane Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 30. North America Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 36. South America Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Guided Tissue Regeneration (GTR) Membrane Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Guided Tissue Regeneration (GTR) Membrane Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Absorbable Membrane
  • Non-absorbable Membrane
Applications
  • Hospital
  • Dental Clinic
Companies covered
  • Geistlich
  • Zimmer Biomet
  • Yantai Zhenghai Bio-tech
  • Botiss Biomaterials
  • Danaher Corporation
  • Sunstar
  • Dentsply Sirona
  • ACE Surgical
  • OraPharma
  • Neoss Limited
  • Keystone Dental
  • BEGO
  • Bioteck
  • Dentegris
  • Genoss

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  4. 1.2.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume (2021-2032)
  5. 1.2.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Guided Tissue Regeneration (GTR) Membrane Market Dynamics
  1. 2.1 Guided Tissue Regeneration (GTR) Membrane Industry Trends
  2. 2.2 Guided Tissue Regeneration (GTR) Membrane Industry Drivers
  3. 2.3 Guided Tissue Regeneration (GTR) Membrane Industry Opportunities and Challenges
  4. 2.4 Guided Tissue Regeneration (GTR) Membrane Industry Restraints
3 Guided Tissue Regeneration (GTR) Membrane Market by Company
  1. 3.1 Global Guided Tissue Regeneration (GTR) Membrane Company Revenue Ranking in 2025
  2. 3.2 Global Guided Tissue Regeneration (GTR) Membrane Revenue by Company (2021-2026)
  3. 3.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Company (2021-2026)
  4. 3.4 Global Guided Tissue Regeneration (GTR) Membrane Average Price by Company (2021-2026)
  5. 3.5 Global Guided Tissue Regeneration (GTR) Membrane Company Ranking (2024-2026)
  6. 3.6 Global Guided Tissue Regeneration (GTR) Membrane Company Manufacturing Base and Headquarters
  7. 3.7 Global Guided Tissue Regeneration (GTR) Membrane Company Product Type and Application
  8. 3.8 Global Guided Tissue Regeneration (GTR) Membrane Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Guided Tissue Regeneration (GTR) Membrane Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Guided Tissue Regeneration (GTR) Membrane Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Guided Tissue Regeneration (GTR) Membrane Market by Type
  1. 4.1 Guided Tissue Regeneration (GTR) Membrane Type Introduction
  2. 4.1.1 Absorbable Membrane
  3. 4.1.2 Non-absorbable Membrane
  4. 4.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type
  5. 4.2.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type
  9. 4.3.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Type (2021-2032)
  11. 4.3.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type (2021-2032)
5 Guided Tissue Regeneration (GTR) Membrane Market by Application
  1. 5.1 Guided Tissue Regeneration (GTR) Membrane Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Dental Clinic
  4. 5.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application
  5. 5.2.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application
  9. 5.3.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Application (2021-2032)
  11. 5.3.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application (2021-2032)
6 Guided Tissue Regeneration (GTR) Membrane Regional Sales and Value Analysis
  1. 6.1 Global Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Guided Tissue Regeneration (GTR) Membrane Sales by Region (2021-2032)
  3. 6.2.1 Global Guided Tissue Regeneration (GTR) Membrane Sales by Region: 2021-2026
  4. 6.2.2 Global Guided Tissue Regeneration (GTR) Membrane Sales by Region (2027-2032)
  5. 6.3 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2021-2032)
  7. 6.4.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region: 2021-2026
  8. 6.4.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Region (2027-2032)
  9. 6.5 Global Guided Tissue Regeneration (GTR) Membrane Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  12. 6.6.2 North America Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  15. 6.7.2 Europe Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  21. 6.9.2 South America Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Guided Tissue Regeneration (GTR) Membrane Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Country, 2025 VS 2032
7 Guided Tissue Regeneration (GTR) Membrane Country-level Sales and Value Analysis
  1. 7.1 Global Guided Tissue Regeneration (GTR) Membrane Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2032)
  4. 7.3.1 Global Guided Tissue Regeneration (GTR) Membrane Sales by Country (2021-2026)
  5. 7.3.2 Global Guided Tissue Regeneration (GTR) Membrane Sales by Country (2027-2032)
  6. 7.4 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2032)
  7. 7.4.1 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2021-2026)
  8. 7.4.2 Global Guided Tissue Regeneration (GTR) Membrane Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Guided Tissue Regeneration (GTR) Membrane Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Geistlich
  2. 8.1.1 Geistlich Company Information
  3. 8.1.2 Geistlich Business Overview
  4. 8.1.3 Geistlich Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Geistlich Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  6. 8.1.5 Geistlich Recent Developments
  7. 8.2 Zimmer Biomet
  8. 8.2.1 Zimmer Biomet Company Information
  9. 8.2.2 Zimmer Biomet Business Overview
  10. 8.2.3 Zimmer Biomet Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zimmer Biomet Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  12. 8.2.5 Zimmer Biomet Recent Developments
  13. 8.3 Yantai Zhenghai Bio-tech
  14. 8.3.1 Yantai Zhenghai Bio-tech Company Information
  15. 8.3.2 Yantai Zhenghai Bio-tech Business Overview
  16. 8.3.3 Yantai Zhenghai Bio-tech Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yantai Zhenghai Bio-tech Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  18. 8.3.5 Yantai Zhenghai Bio-tech Recent Developments
  19. 8.4 Botiss Biomaterials
  20. 8.4.1 Botiss Biomaterials Company Information
  21. 8.4.2 Botiss Biomaterials Business Overview
  22. 8.4.3 Botiss Biomaterials Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Botiss Biomaterials Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  24. 8.4.5 Botiss Biomaterials Recent Developments
  25. 8.5 Danaher Corporation
  26. 8.5.1 Danaher Corporation Company Information
  27. 8.5.2 Danaher Corporation Business Overview
  28. 8.5.3 Danaher Corporation Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Corporation Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  30. 8.5.5 Danaher Corporation Recent Developments
  31. 8.6 Sunstar
  32. 8.6.1 Sunstar Company Information
  33. 8.6.2 Sunstar Business Overview
  34. 8.6.3 Sunstar Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sunstar Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  36. 8.6.5 Sunstar Recent Developments
  37. 8.7 Dentsply Sirona
  38. 8.7.1 Dentsply Sirona Company Information
  39. 8.7.2 Dentsply Sirona Business Overview
  40. 8.7.3 Dentsply Sirona Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dentsply Sirona Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  42. 8.7.5 Dentsply Sirona Recent Developments
  43. 8.8 ACE Surgical
  44. 8.8.1 ACE Surgical Company Information
  45. 8.8.2 ACE Surgical Business Overview
  46. 8.8.3 ACE Surgical Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ACE Surgical Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  48. 8.8.5 ACE Surgical Recent Developments
  49. 8.9 OraPharma
  50. 8.9.1 OraPharma Company Information
  51. 8.9.2 OraPharma Business Overview
  52. 8.9.3 OraPharma Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 OraPharma Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  54. 8.9.5 OraPharma Recent Developments
  55. 8.10 Neoss Limited
  56. 8.10.1 Neoss Limited Company Information
  57. 8.10.2 Neoss Limited Business Overview
  58. 8.10.3 Neoss Limited Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Neoss Limited Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  60. 8.10.5 Neoss Limited Recent Developments
  61. 8.11 Keystone Dental
  62. 8.11.1 Keystone Dental Company Information
  63. 8.11.2 Keystone Dental Business Overview
  64. 8.11.3 Keystone Dental Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Keystone Dental Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  66. 8.11.5 Keystone Dental Recent Developments
  67. 8.12 BEGO
  68. 8.12.1 BEGO Company Information
  69. 8.12.2 BEGO Business Overview
  70. 8.12.3 BEGO Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 BEGO Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  72. 8.12.5 BEGO Recent Developments
  73. 8.13 Bioteck
  74. 8.13.1 Bioteck Company Information
  75. 8.13.2 Bioteck Business Overview
  76. 8.13.3 Bioteck Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bioteck Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  78. 8.13.5 Bioteck Recent Developments
  79. 8.14 Dentegris
  80. 8.14.1 Dentegris Company Information
  81. 8.14.2 Dentegris Business Overview
  82. 8.14.3 Dentegris Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dentegris Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  84. 8.14.5 Dentegris Recent Developments
  85. 8.15 Genoss
  86. 8.15.1 Genoss Company Information
  87. 8.15.2 Genoss Business Overview
  88. 8.15.3 Genoss Guided Tissue Regeneration (GTR) Membrane Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Genoss Guided Tissue Regeneration (GTR) Membrane Product Portfolio
  90. 8.15.5 Genoss Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Guided Tissue Regeneration (GTR) Membrane Value Chain Analysis
  2. 9.1.1 Guided Tissue Regeneration (GTR) Membrane Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Guided Tissue Regeneration (GTR) Membrane Sales Mode & Process
  6. 9.2 Guided Tissue Regeneration (GTR) Membrane Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Guided Tissue Regeneration (GTR) Membrane Distributors
  9. 9.2.3 Guided Tissue Regeneration (GTR) Membrane Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst